Back to the main directory
EarningsReview / Equity
- GreenMobility (Buy, TP: DKK176.00) - Steady drive by DnB Markets
- Grieg Seafood (Buy, TP: NOK100.00) - Soft Q3, but bright outlook by DnB Markets
- Nordea (Buy, TP: SEK126.00) - 12% ROE within reach by DnB Markets
- Borregaard (Buy, TP: NOK260.00) - Promising margin picture by DnB Markets
- ABB (Hold, TP: SEK305.00) - Demand up but supply challenged by DnB Markets
- Atlas Copco (Hold, TP: SEK575.00) - Delivery pain, order gain by DnB Markets
- DNB (No_rec, TP: NOK) - Set for NII expansion by DnB Markets
- Axfood (Hold, TP: SEK216.00) - Solid Q3 results by DnB Markets
- Not even the Fed''s transitory inflation can slow TSCO by BNP Paribas Exane
- Walmex (WALMEX* MM) by HSBC
- L&T Finance Holding (LTFH IN) by HSBC
- Will the shipping stop the shopping? by BNP Paribas Exane
- Q321 sales and 15 questions for management by BNP Paribas Exane
- SAP reminds us 2022 is still a transition year by BNP Paribas Exane
- Volvo - Buy/SEK 240 (235): Stellar profitability despite the headwinds by Nordea
- Supportive news offset short term pressure on margin by BNP Paribas Exane
- DNB - Sell/NOK 182 (178): Peak fee growth, baton passed to the NIM by Nordea
- A good start to the new era by BNP Paribas Exane
- Graenges - Hold (Buy/SEK 135): Short-term headwinds too severe to ignore by Nordea
- F-Secure - Buy/EUR 5.70 (5.50): Accelerating growth in corporate security products by Nordea
- Swedbank - Hold: Richly rewarded for a decent Q3 report by Nordea
- ESG: Trick or Treatment? by BNP Paribas Exane
- Gränges - Stay away until its stops getting worse by Danske Bank Equity Research
- Santander CIB: SAP: 3Q21: Still a Long Way to Go by Santander
- Strong Q3 revenues and conservative 2021 guidance by BNP Paribas Exane
- LeoVegas (Buy, TP: SEK50.00) - Waiting for Sweden to lift restrictions by DnB Markets
- Topdanmark (Hold, TP: DKK330.00) - Solid quarter by DnB Markets
- Swedbank (Hold, TP: SEK202.00) - Encouraging signs by DnB Markets
- Rana Gruber (Buy, TP: NOK65.00) - More normalised profitability by DnB Markets
- BioArctic (Buy, TP: SEK250.00) - Moving closer to market launch by DnB Markets
- Atlas Copco (Hold, TP: SEK575.00) - Delivery pain, order gain by DnB Markets
- Gentian Diagnostics (Buy, TP: NOK96.00) - A mixed bag by DnB Markets
- Favourable trends at the moment by BNP Paribas Exane
- Itaú BBA on Kimberly Clark de México: Soaring Cost Pressure Drives Major ESP Miss in 3Q21 by Itau
- THG Plc (THG LN) by HSBC
- UK net zero strategy revealed by BNP Paribas Exane
- A step forward by BNP Paribas Exane
- Short term pain certain, long term gain uncertain by BNP Paribas Exane
- Keeping a lid on expectations by BNP Paribas Exane
- Waiting for the right growth opportunity by BNP Paribas Exane
- Axfood - Sell/SEK 170 (150): The near-term comparison base looks challenging by Nordea
- Huhtamaki - Hold: Inflationary environment to persist in Q4 by Nordea
- Alma Media - Buy/EUR 14 (13): Stronger-than-anticipated market recovery by Nordea
- Telia Company - Buy/SEK 46: The worst is behind us by Nordea
- Nordea Bank - No Rating: Slightly soft Q3 but solid momentum by Nordea
- Topdanmark - Buy/DKK 400: Strong momentum but weak communication by Nordea
- Intrum - Buy/SEK 305 (310): Continued NPL optimism ahead of 2022 by Nordea
- Revenio Group - Hold: Consensus expectations for Q4 and for 2022 a risk by Nordea
- Roadshow feedback by BNP Paribas Exane
- INVEST SECURITIES - HERMES : La croissance continue d'éluder la valo… - ACHAT, OC 975€ (vs 991€) by Invest Securities